Use of amygdalin analogues for the treatment of psoriasis

323332 1314131421314 The compounds of formula (I), wherein n is an integer from 0 to 4; R1 is a radical selected from the group consisting of H, CH, CH-CH, C(CH), COOH, CONHand C≡CH; R2, R3, R4 and R5 are radicals independently selected from the group consisting of H, F, Cl, Br, (C-C)-alkoxyl and (C-C)-alkyl; and R6 is a radical selected from the group consisting of H, F, Cl, Br, (C-C)-alkoxyl, (C-C)-alkyl, R7, CH═CH-R7 and O-CH-R7; wherein R7 is phenyl or phenyl mono- or independently di-substituted with F, Cl, Br, (C-C)-alkoxyl or (C-C)-alkyl, exhibit a similar chemotactic index to that of amygdalin (natural product whose chemotaxis profile is similar to that of peptide T) and, consequently, are useful for treating inflammatory and/or allergic dermatophathies, such as psoriasis, and are especially much less toxic than amygdalin.